Poland· PL-100064758

Sylimarol 35 mg

A silymarin product containing silybi mariani fructus extractum siccum, registered in Poland by Poznańskie Zakłady Zielarskie "Herbapol" S.A.. The same ATC class is registered in 5 of our 19 countries.

ATC A05BA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSylimarol 35 mgATCA05BA03REGISTER NO.PL-100064758PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Silymarin is registered in 5 of 19 countries.

Countries holding a registration under ATC A05BA03 (silymarin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Silymarin · ATC A05BA03

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Silybi mariani fructus extractum siccum
Manufacturer
Poznańskie Zakłady Zielarskie "Herbapol" S.A.
Country
Poland (PL)
ATC code
A05BA03
ATC class
Silymarin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990378814
  • gtin
    05909990776306

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Silymarin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silymarin products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Bulgaria · Карсил, Карсил Макс
  • Czechia · Lagosa
  • Germany · Silymarin Ct, Silymarin Forte Stada
  • Spain · Legalon
  • France · Legalon
  • Croatia · Silymarin Belupo, Silymarin Forte Belupo
  • Italy · Silimarin, Silmar
  • Portugal · Legalon
  • Romania · Silibină Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7f0d7c9c-ff84-443f-8b4d-f423ad26bc9f
GET /v1/drugs/7f0d7c9c-ff84-443f-8b4d-f423ad26bc9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "35 mg",
  "packaging": "05909990378814 ¦ OTC ¦ 57604\n60 tabl.\n05909990776306 ¦ OTC ¦ 57605\n30 tabl.",
  "substance": "Silybi mariani extractum siccum 50 mg; ekstrahent - metanol 90%, substancja pomocnicza - benzoesan sodu (<0,2%)",
  "common_name": "Silybi mariani fructus extractum siccum",
  "pl_product_id": "100064758",
  "pozwolenie_nr": "03788",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about silymarin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.